Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xianjun Yu

Showing results (281-290 of 421) with videos related to

Pageof 43
Sort By:
BMC Surgery|December 21, 2024
Topical application of Glauber's salt accelerates the absorption of abdominal fluid after pancreatectomyJialin Li, Jie Hua, Haiyan Ruan, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2024
DNA hypo-methylation and expression of GBP4 induces T cell exhaustion in pancreatic cancerYesiboli Tasiheng, Xuan Lin, Xu Wang, et al.
Computational and Structural Biotechnology Journal|May 1, 2024
Integration of single-nucleus and exosome RNA sequencing dissected inter-cellular communication and biomarkers in pancreatic ductal adenocarcinomaRong Tang, Zifeng Zhang, Jin Xu, et al.
Oncology Letters|April 30, 2017
Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumorsYuhong Wang, Wei Wang, Kaizhou Jin, et al.
Endocrine|August 31, 2020
High pre-operative fasting blood glucose levels predict a poor prognosis in patients with pancreatic neuroendocrine tumourYitao Gong, Zhiyao Fan, Pin Zhang, et al.
Annals of Surgical Oncology|March 8, 2020
Prognostic Value of the C-Reactive Protein/Lymphocyte Ratio in Pancreatic CancerZhiyao Fan, Guopei Luo, Yitao Gong, et al.
Oncology Reports|August 3, 2017
FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1Qiangsheng Hu, Yi Qin, Bo Zhang, et al.
Cancer Letters|March 16, 2025
Pentose phosphate recycling driven by Gli1 contributes to chemotherapy resistance in cancer cellsQiangsheng Hu, Cong Jiang, Yi Qin, et al.
Cancer Letters|August 31, 2024
YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancerBorui Li, Faliang Xing, Jingyi Wang, et al.
Experimental Cell Research|May 6, 2024
PITX2 functions as a transcription factor for GPX4 and protects pancreatic cancer cells from ferroptosisZhiliang Wang, Di Wu, Yue Zhang, et al.
Pageof 43

Showing results (281-290 of 421) with videos related to

Sort By:
Pageof 43
BMC Surgery|December 21, 2024
Topical application of Glauber's salt accelerates the absorption of abdominal fluid after pancreatectomyJialin Li, Jie Hua, Haiyan Ruan, et al.
Cancer Immunology, Immunotherapy : CII|August 7, 2024
DNA hypo-methylation and expression of GBP4 induces T cell exhaustion in pancreatic cancerYesiboli Tasiheng, Xuan Lin, Xu Wang, et al.
Computational and Structural Biotechnology Journal|May 1, 2024
Integration of single-nucleus and exosome RNA sequencing dissected inter-cellular communication and biomarkers in pancreatic ductal adenocarcinomaRong Tang, Zifeng Zhang, Jin Xu, et al.
Oncology Letters|April 30, 2017
Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumorsYuhong Wang, Wei Wang, Kaizhou Jin, et al.
Endocrine|August 31, 2020
High pre-operative fasting blood glucose levels predict a poor prognosis in patients with pancreatic neuroendocrine tumourYitao Gong, Zhiyao Fan, Pin Zhang, et al.
Annals of Surgical Oncology|March 8, 2020
Prognostic Value of the C-Reactive Protein/Lymphocyte Ratio in Pancreatic CancerZhiyao Fan, Guopei Luo, Yitao Gong, et al.
Oncology Reports|August 3, 2017
FBW7 increases the chemosensitivity of pancreatic cancer cells to gemcitabine through upregulation of ENT1Qiangsheng Hu, Yi Qin, Bo Zhang, et al.
Cancer Letters|March 16, 2025
Pentose phosphate recycling driven by Gli1 contributes to chemotherapy resistance in cancer cellsQiangsheng Hu, Cong Jiang, Yi Qin, et al.
Cancer Letters|August 31, 2024
YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancerBorui Li, Faliang Xing, Jingyi Wang, et al.
Experimental Cell Research|May 6, 2024
PITX2 functions as a transcription factor for GPX4 and protects pancreatic cancer cells from ferroptosisZhiliang Wang, Di Wu, Yue Zhang, et al.
Pageof 43